Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

10x Genomics (TXG) Asset Utilization Ratio (2019 - 2026)

10x Genomics' Asset Utilization Ratio history spans 7 years, with the latest figure at 0.62 for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio fell 5.56% to 0.62 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.62, a 5.56% decrease, with the full-year FY2025 number at 0.66, up 1.15% from a year prior.
  • Asset Utilization Ratio hit 0.62 in Q4 2025 for 10x Genomics, down from 0.64 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for TXG hit a ceiling of 0.69 in Q1 2025 and a floor of 0.35 in Q1 2021.
  • Historically, Asset Utilization Ratio has averaged 0.57 across 5 years, with a median of 0.59 in 2023.
  • The widest YoY moves for Asset Utilization Ratio: up 61.06% in 2021, down 18.67% in 2021.
  • Tracing TXG's Asset Utilization Ratio over 5 years: stood at 0.49 in 2021, then rose by 4.46% to 0.51 in 2022, then grew by 26.79% to 0.65 in 2023, then increased by 1.76% to 0.66 in 2024, then dropped by 5.56% to 0.62 in 2025.
  • Business Quant data shows Asset Utilization Ratio for TXG at 0.62 in Q4 2025, 0.64 in Q3 2025, and 0.68 in Q2 2025.